Business Context and Reporting Period
Company: Ocular Therapeutix, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 10, 2016
Reporting Period: Quarter ended March 31, 2016
Context: The filing announces the Company's financial results for the quarter ended March 31, 2016. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide specific values for the following metrics:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt
- Liquidity
Note: Specific financial figures are not present in the provided 8-K text and must be sourced from the referenced Exhibit 99.1.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. It only confirms the announcement of results for the quarter ended March 31, 2016.
Guidance, Outlook, and Risks
The provided text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. These details are expected to be found in the incorporated press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 10, 2016) for actual revenue, net loss, and cash position figures.
- Verify the specific clinical or operational milestones achieved during the quarter ended March 31, 2016.
- Check for any updated guidance or liquidity runway projections in the full press release.
- Confirm the status of the Company's cash and cash equivalents to assess operational runway.